Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure
Paccaly, Anne, Frick, Annke, Rohatagi, Shashank, Liu, Jingli, Shukla, Umesh, Rosenburg, Ronald, Hinder, Markus, Jensen, Bradford K
Published in Journal of clinical pharmacology (01.01.2006)
Published in Journal of clinical pharmacology (01.01.2006)
Get more information
Journal Article
Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM)
Zannikos, P N, Rohatagi, S, Jensen, B K, DePhillips, S L, Rhodes, G R
Published in Journal of clinical pharmacology (01.10.2000)
Published in Journal of clinical pharmacology (01.10.2000)
Get more information
Journal Article
Pharmacokinetic/pharmacodynamic relationships for otamixaban, a direct factor Xa inhibitor, in healthy subjects
Paccaly, Anne, Frick, Annke, Ozoux, Marie-Laure, Chu, Valeria, Rosenburg, Ronald, Hinder, Markus, Shukla, Umesh, Jensen, Bradford K
Published in Journal of clinical pharmacology (01.01.2006)
Published in Journal of clinical pharmacology (01.01.2006)
Get more information
Journal Article
Pharmacokinetics, pharmacodynamics, and safety of a lipid-lowering adenosine A1 agonist, RPR749, in healthy subjects
Shah, Bharti, Rohatagi, Shashank, Natarajan, Chandrasekhar, Kirkesseli, Stephane, Baybutt, Robert, Jensen, Bradford K
Published in American journal of therapeutics (01.05.2004)
Published in American journal of therapeutics (01.05.2004)
Get more information
Journal Article
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: A case study with fexofenadine hydrochloride
Krishna, Rajesh, Krishnaswami, Sriram, Kittner, Barbara, Sankoh, Abdul J., Jensen, Bradford K.
Published in Biopharmaceutics & drug disposition (01.12.2004)
Published in Biopharmaceutics & drug disposition (01.12.2004)
Get full text
Journal Article
Pharmacoscintigraphic comparison of HMR 1031, a VLA-4 antagonist, in healthy volunteers following delivery via a nebulizer and a dry powder inhaler
Rohatagi, Shashank, Chapel, Sunny, Kirkesseli, Stephane, Newman, Stephen, Zhang, Jie, Paccaly, Dominique, Randall, Linda, Wray, H, Wellington, Sheree, Shah, Bharti, Jensen, Bradford K
Published in American journal of therapeutics (01.03.2004)
Published in American journal of therapeutics (01.03.2004)
Get more information
Journal Article
Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers
Emmons, Gary T, Argenti, Rick, Martin, Louis L, Martin, Nancy E, Jensen, Bradford K
Published in Journal of clinical pharmacology (01.08.2004)
Published in Journal of clinical pharmacology (01.08.2004)
Get more information
Journal Article
Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects
Shah, Bharti, Emmons, Gary, Rohatagi, Shashank, Martin, Nancy E, Jensen, Bradford K
Published in American journal of therapeutics (01.09.2003)
Published in American journal of therapeutics (01.09.2003)
Get more information
Journal Article
A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration
Argenti, D, Jensen, B K, Hensel, R, Bordeaux, K, Schleimer, R, Bickel, C, Heald, D
Published in Journal of clinical pharmacology (01.07.2000)
Published in Journal of clinical pharmacology (01.07.2000)
Get more information
Journal Article
Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers
Zannikos, P N, Rohatagi, S, Jensen, B K, DePhillips, S L, Massignon, D, Calic, F, Sibille, M, Kirkesseli, S
Published in Journal of clinical pharmacology (01.11.2000)
Published in Journal of clinical pharmacology (01.11.2000)
Get more information
Journal Article
Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers
Zannikos, P N, Baybutt, R I, Boutouyrie, B X, Shah, B, Hunt, T L, Jensen, B K
Published in Journal of clinical pharmacology (01.10.1999)
Published in Journal of clinical pharmacology (01.10.1999)
Get more information
Journal Article
Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency
Zannikos, P N, Jensen, B K, Boutouyrie, B X, Tripp, L, Yongyi, L, McGowan, T, Waldman, S A, Greenberg, H E
Published in Journal of clinical pharmacology (01.07.2000)
Published in Journal of clinical pharmacology (01.07.2000)
Get more information
Journal Article
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of the TIMI 15A and 15B trials
Giugliano, Robert P., McCabe, Carolyn H., Sequeira, Rafael F., Frey, Martin J., Henry, Timothy D., Piana, Robert N., Tamby, Jean-Francois, Jensen, Bradford K., Nicolas, Sylvain B., Jennings, Lisa K., Wise, Robert J., Braunwald, Eugene
Published in The American heart journal (01.07.2000)
Published in The American heart journal (01.07.2000)
Get full text
Journal Article
Conference Proceeding
Negligible systemic absorption of topical isotretinoin cream: implications for teratogenicity
Chen, C, Jensen, B K, Mistry, G, Wyss, R, Zultak, M, Patel, I H, Rakhit, A K
Published in Journal of clinical pharmacology (01.04.1997)
Published in Journal of clinical pharmacology (01.04.1997)
Get more information
Journal Article
Effects of food on the pharmacokinetics of sparfloxacin
Johnson, Robert D., Dorr, Mary Beth, Hunt, Thomas L., Jensen, Bradford K., Talbot, George H.
Published in Clinical therapeutics (01.06.1999)
Published in Clinical therapeutics (01.06.1999)
Get full text
Journal Article